SAMSON MARVIN 4
4 · ANTARES PHARMA, INC. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
SAMSON MARVIN
Director
Transactions
- Exercise/Conversion
Common Stock
2019-12-23$1.12/sh+150,000$168,000→ 201,751 total - Sale
Common Stock
2019-12-23$4.71/sh−150,000$706,500→ 51,751 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-23−150,000→ 0 totalExercise: $1.12From: 2016-06-02Exp: 2026-06-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.